Cargando…

Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells

BACKGROUND: Medulloblastoma is the most common malignant brain tumor in children and remains a therapeutic challenge due to its significant therapy-related morbidity. Polo-like kinase 1 (PLK1) is highly expressed in many cancers and regulates critical steps in mitotic progression. Recent studies sug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Peter S, Venkataraman, Sujatha, Alimova, Irina, Birks, Diane K, Donson, Andrew M, Knipstein, Jeffrey, Dubuc, Adrian, Taylor, Michael D, Handler, Michael H, Foreman, Nicholas K, Vibhakar, Rajeev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311601/ https://www.ncbi.nlm.nih.gov/pubmed/22390279 http://dx.doi.org/10.1186/1471-2407-12-80

Ejemplares similares

MPS1 kinase as a potential therapeutic target in medulloblastoma
por: Alimova, Irina, et al.
Publicado: (2016)

Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma
por: Amani, Vladimir, et al.
Publicado: (2016)

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma
por: Harris, Peter S, et al.
Publicado: (2014)

Targeting Polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor
por: Alimova, Irina, et al.
Publicado: (2017)

Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma
por: Venkataraman, Sujatha, et al.
Publicado: (2014)

Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma
por: Prince, Eric W., et al.
Publicado: (2016)

MicroRNA 128a Increases Intracellular ROS Level by Targeting Bmi-1 and Inhibits Medulloblastoma Cancer Cell Growth by Promoting Senescence
por: Venkataraman, Sujatha, et al.
Publicado: (2010)

A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma
por: Wang, Dong, et al.
Publicado: (2021)

MEDB-44. Transcriptomic resolution of subgroup-specific medulloblastoma architecture
por: Willard, Nicholas, et al.
Publicado: (2022)

MBRS-46. CHARTING NEOPLASTIC AND IMMUNE CELL HETEROGENEITY IN HUMAN AND GEM MODELS OF MEDULLOBLASTOMA USING scRNAseq
por: Donson, Andrew, et al.
Publicado: (2020)

MBRS-65. FBXW7 ACTS A TUMOR SUPPRESSOR IN MYC-DRIVEN MEDULLOBLASTOMA BY CONTROLLING A FEED-FORWARD REGULATORY LOOP OF PLK1 AND MYC
por: Wang, Dong, et al.
Publicado: (2020)

Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma
por: Bhatia, Shilpa, et al.
Publicado: (2017)

EMBR-27. NEOPLASTIC AND IMMUNE SINGLE CELL TRANSCRIPTOMICS DEFINE SUBGROUP-SPECIFIC INTRA-TUMORAL HETEROGENEITY OF CHILDHOOD MEDULLOBLASTOMA
por: Donson, Andrew, et al.
Publicado: (2021)

EPEN-31. SINGLE-CELL RNAseq OF CHILDHOOD EPENDYMOMA REVEALS DISTINCT NEOPLASTIC CELL SUBPOPULATIONS THAT IMPACT ETIOLOGY, MOLECULAR CLASSIFICATION AND OUTCOME
por: Donson, Andrew, et al.
Publicado: (2020)

Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumors
por: Alimova, Irina, et al.
Publicado: (2022)

XRT-02. SINGLE-CELL RNA SEQUENCING IDENTIFIES FUNCTIONAL MACROPHAGE SUBSETS THAT ARE ENRICHED IN RESPONSE TO DIFFERENTIAL PHAGOCYTOSIS INDUCTION AGAINST GLIOMA
por: Lakshmanachetty, Senthilnath, et al.
Publicado: (2023)

MEDB-80. CDK8 promotes stemness of MYC-driven medulloblastoma
por: Wang, Dong, et al.
Publicado: (2022)

MEDB-70. Metabolism mediated radiation resistance in MYC-driven Medulloblastoma
por: Veo, Bethany, et al.
Publicado: (2022)

MEDB-81. Combined inhibition of CDK11 and EZH2 results in regression of MYC-amplified medulloblastoma
por: Wang, Dong, et al.
Publicado: (2022)

SMYD3 Promotes Cell Cycle Progression by Inducing Cyclin D3 Transcription and Stabilizing the Cyclin D1 Protein in Medulloblastoma
por: Asuthkar, Swapna, et al.
Publicado: (2022)

MEDB-28. CDK9 is a druggable mediator sustaining Myc-driven circuitry in medulloblastoma
por: Madhavan, Krishna, et al.
Publicado: (2022)

ATRT-06. SMARCB1 LOSS DRIVEN NON-CANONICAL PRC1 ACTIVITY REGULATES DIFFERENTIATION IN ATYPICAL TERATOID RHABDOID TUMORS (ATRT)
por: Alimova, Irina, et al.
Publicado: (2020)

ATRT-23. SIRT2 cooperates with SMARCB1 to induce a differentiation block in ATRT
por: Alimova, Irina, et al.
Publicado: (2022)

MDB-37. CDK9 IS A DRUGGABLE MEDIATOR SUSTAINING MYC-DRIVEN TRANSCRIPTIONAL CIRCUITRY IN MEDULLOBLASTOMA
por: Krishna, Madhavan, et al.
Publicado: (2023)

Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
por: Hoffmann, Ingrid
Publicado: (2022)

Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma
por: Sredni, Simone Treiger, et al.
Publicado: (2017)

EPEN-26. NON-CANONICAL NF-κB SIGNALING DRIVES MESENCHYMAL EPENDYMAL CELL SUBPOPULATION IN PFA EPENDYMOMA
por: Griesinger, Andrea, et al.
Publicado: (2020)

Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)
por: Jani, Krupa S., et al.
Publicado: (2012)

Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication
por: Song, Bing, et al.
Publicado: (2012)

Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis
por: Purvis, Ian J., et al.
Publicado: (2019)

Unique Molecular Characteristics of Pediatric Myxopapillary Ependymoma
por: Barton, Valerie N., et al.
Publicado: (2009)

Targeting Echinococcus multilocularis Stem Cells by Inhibition of the Polo-Like Kinase EmPlk1
por: Schubert, Andreas, et al.
Publicado: (2014)

Pericentriolar matrix (PCM) integrity relies on cenexin and polo-like kinase (PLK)1
por: Aljiboury, Abrar, et al.
Publicado: (2022)

IMG-17. RADIOMICS CHARACTERIZATION OF FOUR PEDIATRIC BRAIN TUMOR SUBTYPES IN PDX MOUSE MODELS
por: Serkova, Natalie, et al.
Publicado: (2020)

DIPG-73. SENESCENCE ASSOCIATED SECRETORY PHENOTYPE AS A MECHANISM OF RESISTANCE AND THERAPEUTIC VULNERABILITY IN BMI1 INHIBITOR TREATED DIPG
por: Balakrishnan, Ilango, et al.
Publicado: (2020)

Regulating a key mitotic regulator, polo‐like kinase 1 (PLK1)
por: Colicino, Erica G., et al.
Publicado: (2018)

PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy
por: Ruf, Stefanie, et al.
Publicado: (2017)

Mechanisms Underlying Plk1 Polo-Box Domain-Mediated Biological Processes and Their Physiological Significance
por: Lee, Kyung S., et al.
Publicado: (2014)

MBRS-67. ROLE OF CYCLIN DEPENDENT KINASE-9 IN Myc-ENHANCED MEDULLOBLASTOMA
por: Madhavan, Krishna, et al.
Publicado: (2020)

Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination
por: Biswas, Ayan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ctcss6pl86nms2cisj59c9mrn1